Eternal Forecasts 2003 Sales for Sheep Embryonic Transfer Division


HOUSTON, July 9 /PRNewswire-FirstCall/  -- Eternal Technologies,  Inc. (Bulletin
Board:  ETLT) today  announced that  preliminary  sales  forecasts for its sheep
embryonic transfer division should amount to $5.32 million while net profits for
the  division are  expected to be $4.27  million  when annual  plant  production
reaches 2,000 tons.  Sales are projected to be increased by an additional  $11.6
million and gross  profit  increased  an  additional  $3.3  million over present
operations when annual output is 4,000 tons.


Eternal also announced that it will expand its geographic market  penetration to
include  Inner  Mongolia and Gansu since demand has  increased  dramatically  in
those  regions  for  Eternal's  products.  The  Company  expects to  transfer an
additional  1,800  embryos  for a total of 7,800 for 2003.  Eternal  is  seeking
funding to meet these expansion goals.

Jijun Wu, Chairman of Eternal  Technologies,  stated,  "High demand necessitated
the recent  opening of Eternal's AnBo Embryo Biotech Center in Beijing to handle
the production of embryonic transfers. Since the facility opened, costs of sales
have  decreased  by over 50% since the plant  allowed  Eternal  to  develop  and
process  products   domestically  instead  of  through  importation  from  other
countries.  Through opening our facility in the heart of the country's  capital,
Eternal  has been able to capture  significant  market  share and  maintain  our
dominant position as the largest embryonic transfer company in China."

About Eternal  Technologies  Group Eternal  Technologies  Group is China's major
agricultural  genetics  and  bio-  pharmaceutical  R&D firm  operating  with the
support of the Chinese Government.

Safe Harbor  Statement  Under The Private  Securities  Litigation  Reform Act of
1995:  The  statements  in the  press  release  that  relate  to  the  company's
expectations  with regard to the future impact on the company's results from new
products in development are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. The results anticipated by any
or all of these forward-looking statements may not occur.